Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01466179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: Blinatumomab

Sponsor

Amgen Research (Munich) GmbH